Ivax Diagnostics, Inc. (IVD) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-1.57M
Depreciation and amortization	538.13K
Net provision for doubtful accounts receivable	-7.26K
Provision for inventory obsolescence
Non-cash compensation expense	46.75K
Deferred income taxes	34.39K
Accounts receivable	248.7K
Inventories	-1.26M
Other current assets	-572.62K
Other assets
Accounts payable and accrued expenses	468.75K
Other long-term liabilities	-21.74K
Net cash flows used in operating activities	-2.16M
Capital expenditures	-249.71K
Restricted deposits	32.62K
Acquisition of equipment on lease	-122.21K
Sale of equipment
Net cash flows used in investing activities	-339.3K
Proceeds of share offering
Proceeds of revolving line of credit	1.56M
Exercise of stock options	0
Capital lease payments
Net cash flows provided by (used in) financing activities	1.56M
Effect of exchange rate changes on cash and cash equivalents	-11.96K
Net increase (decrease) in cash and cash equivalents	-951.91K
Cash and cash equivalents at the beginning of the period	2.55M
Cash and cash equivalents at the end of the period	1.6M
Acquisition of equipment using capital lease

Entities mentioned with IVD

View All Entities